Literature DB >> 25521179

Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights.

Gabriele C DeLuca1, Richard L Yates, Harry Beale, Sarah A Morrow.   

Abstract

Cognitive impairment is a common and debilitating feature of multiple sclerosis (MS) that has only recent gained considerable attention. Clinical neuropsychological studies have made apparent the multifaceted nature of cognitive troubles often encountered in MS and continue to broaden our understanding of its complexity. Radiographic studies have started to decipher the neuroanatomic substrate of MS-related cognitive impairment and have shed light onto its pathogenesis. Where radiographic studies have been limited by inadequate resolution or non-specificity, pathological studies have come to the fore. This review aims to provide an overview of the nature of cognitive impairment typically seen in MS and to explore the literature on imaging and pathological studies relevant to its evolution. In particular, the relative contributions of gray (i.e., cerebral cortex, hippocampus, thalamus and basal ganglia) and white matter to MS-related cognitive impairment will be discussed and the importance of interconnectivity between structures highlighted. The pressing need for longitudinal studies combining standardized neuropsychometric, paraclinical and radiographic outcomes obtained during life with post-mortem tissue analysis after death is presented.
© 2014 International Society of Neuropathology.

Entities:  

Keywords:  cognitive impairment; gray matter; imaging; multiple sclerosis; pathology; white matter

Mesh:

Year:  2015        PMID: 25521179     DOI: 10.1111/bpa.12220

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  41 in total

1.  Prevalence and incidence of cognitive impairment in multiple sclerosis: a population-based survey in Catania, Sicily.

Authors:  Francesco Patti; Alessandra Nicoletti; Silvia Messina; Elisa Bruno; Salvatore Lo Fermo; Graziella Quattrocchi; Clara Grazia Chisari; Davide Maimone; Sabina Cilia; Mario Zappia
Journal:  J Neurol       Date:  2015-02-07       Impact factor: 4.849

Review 2.  Social Cognition in Multiple Sclerosis: a Meta-Analysis.

Authors:  Emre Bora; Serkan Özakbaş; Dennis Velakoulis; Mark Walterfang
Journal:  Neuropsychol Rev       Date:  2016-06-20       Impact factor: 7.444

3.  Changes in Cognitive Performance With Age in Adults With Multiple Sclerosis.

Authors:  Jessica F Baird; Katie L J Cederberg; E Morghen Sikes; Brenda Jeng; Jeffer E Sasaki; Brian M Sandroff; Robert W Motl
Journal:  Cogn Behav Neurol       Date:  2019-09       Impact factor: 1.600

4.  Motoric cognitive risk syndrome in people with multiple sclerosis: prevalence and correlations with disease-related factors.

Authors:  Sapir Dreyer-Alster; Shay Menascu; Roy Aloni; Uri Givon; Mark Dolev; Anat Achiron; Alon Kalron
Journal:  Ther Adv Neurol Disord       Date:  2022-07-04       Impact factor: 6.430

5.  Reduced GABA levels correlate with cognitive impairment in patients with relapsing-remitting multiple sclerosis.

Authors:  Guanmei Cao; Richard A E Edden; Fei Gao; Hao Li; Tao Gong; Weibo Chen; Xiaohui Liu; Guangbin Wang; Bin Zhao
Journal:  Eur Radiol       Date:  2017-10-06       Impact factor: 5.315

6.  Cognition in older patients with multiple sclerosis compared to patients with amnestic mild cognitive impairment and healthy older adults.

Authors:  Alexandra K Roth; Douglas R Denney; Jeffrey M Burns; Sharon G Lynch
Journal:  Neuropsychology       Date:  2018-06-25       Impact factor: 3.295

7.  Longitudinal Stability of Cognition in Early-Phase Relapsing-Remitting Multiple Sclerosis: Does Cognitive Reserve Play a Role?

Authors:  Roxana M Barbu; Jason A Berard; Louise M Gresham; Lisa A S Walker
Journal:  Int J MS Care       Date:  2018 Jul-Aug

Review 8.  Age-related small vessel disease: a potential contributor to neurodegeneration in multiple sclerosis.

Authors:  Ruth Geraldes; Margaret M Esiri; Gabriele C DeLuca; Jacqueline Palace
Journal:  Brain Pathol       Date:  2017-03-12       Impact factor: 6.508

Review 9.  Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players.

Authors:  Dániel Sandi; Zsanett Fricska-Nagy; Krisztina Bencsik; László Vécsei
Journal:  Molecules       Date:  2021-06-05       Impact factor: 4.411

10.  Remotely Supervised Transcranial Direct Current Stimulation Increases the Benefit of At-Home Cognitive Training in Multiple Sclerosis.

Authors:  Leigh Charvet; Michael Shaw; Bryan Dobbs; Ariana Frontario; Kathleen Sherman; Marom Bikson; Abhishek Datta; Lauren Krupp; Esmail Zeinapour; Margaret Kasschau
Journal:  Neuromodulation       Date:  2017-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.